Ontology type: schema:ScholarlyArticle
1998-06-29
AUTHORSJ Hara, Y Osugi, H Ohta, Y Matsuda, K Nakanishi, K Takai, H Fujisaki, S Tokimasa, M Fukuzawa, A Okada, S Okada
ABSTRACTMajor dose-limiting factors of high-dose thiotepa (TEPA) and melphalan are life-threatening mucositis and neurotoxicity. To administer a maximum dose of these drugs safely and to obtain a maximum anti-cancer effect, a double-conditioning regimen with a single grafting, two cycles of administration of a combination of TEPA (300–600 mg/m2) plus melphalan (70–150 mg/m2) with a 1-week interval was attempted in 20 patients with pediatric advanced or chemotherapy-resistant solid tumors (seven rhabdomyosarcoma, four hepatoblastoma, three neuroblastoma and four other malignancy). Combinations of TEPA plus melphalan/busulfan (Bu) (8–10 mg/kg) and TEPA plus Bu were given to four and two patients with brain tumors, respectively. In an additional two patients, three cycles of drug administration were performed. According to the results of the dose-escalating study, the maximum tolerable doses of TEPA and melphalan for children aged 2 years old or older were 1000 mg/m2 and 280 mg/m2, respectively. Mucositis was dose-limiting. Renal toxicity was also dose-limiting in young children (<2 years old). there were two treatment-related deaths (7%) (fungal pneumonia and renal tubular acidosis). among 13 patients who received high-dose chemotherapy during cr, 10 are alive with no evidence of disease (15–59 months, median: 35 months) and in 13 evaluable patients without cr, six are alive without regrowth of the disease (14–59 months, median: 39 months). thus, these novel conditioning regimens allowed us to increase the dose intensity to nearly the maximum for each drug and seemed to reduce adverse effects compared to previously reported regimens with these drugs. with regard to the effect on outcome, the results of this study seem to be encouraging, but a further study on a larger number of patients is required. More... »
PAGES7-12
http://scigraph.springernature.com/pub.10.1038/sj.bmt.1701283
DOIhttp://dx.doi.org/10.1038/sj.bmt.1701283
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1012091956
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/9678789
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adolescent",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Agranulocytosis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Combined Chemotherapy Protocols",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Busulfan",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Child",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Child, Preschool",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hematopoietic Stem Cell Transplantation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Infant",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Melphalan",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Thiotepa",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Thrombocytopenia",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Transplantation Conditioning",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.136593.b",
"name": [
"Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Hara",
"givenName": "J",
"id": "sg:person.01154453452.69",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154453452.69"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.136593.b",
"name": [
"Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Osugi",
"givenName": "Y",
"id": "sg:person.01172100025.27",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172100025.27"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.136593.b",
"name": [
"Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Ohta",
"givenName": "H",
"id": "sg:person.01152115360.23",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152115360.23"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.136593.b",
"name": [
"Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Matsuda",
"givenName": "Y",
"id": "sg:person.01322175505.03",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322175505.03"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.136593.b",
"name": [
"Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Nakanishi",
"givenName": "K",
"id": "sg:person.016573776302.21",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016573776302.21"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.136593.b",
"name": [
"Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Takai",
"givenName": "K",
"id": "sg:person.0673307625.97",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673307625.97"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.136593.b",
"name": [
"Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Fujisaki",
"givenName": "H",
"id": "sg:person.0772111652.27",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772111652.27"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.136593.b",
"name": [
"Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Tokimasa",
"givenName": "S",
"id": "sg:person.01106576551.49",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106576551.49"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatric Surgery, Osaka University School of Medicine, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.136593.b",
"name": [
"Department of Pediatric Surgery, Osaka University School of Medicine, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Fukuzawa",
"givenName": "M",
"id": "sg:person.01176624231.59",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176624231.59"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatric Surgery, Osaka University School of Medicine, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.136593.b",
"name": [
"Department of Pediatric Surgery, Osaka University School of Medicine, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Okada",
"givenName": "A",
"id": "sg:person.0725725344.49",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725725344.49"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan",
"id": "http://www.grid.ac/institutes/grid.136593.b",
"name": [
"Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Okada",
"givenName": "S",
"id": "sg:person.010007364502.54",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010007364502.54"
],
"type": "Person"
}
],
"datePublished": "1998-06-29",
"datePublishedReg": "1998-06-29",
"description": "Major dose-limiting factors of high-dose thiotepa (TEPA) and melphalan are life-threatening mucositis and neurotoxicity. To administer a maximum dose of these drugs safely and to obtain a maximum anti-cancer effect, a double-conditioning regimen with a single grafting, two cycles of administration of a combination of TEPA (300\u2013600\u2009mg/m2) plus melphalan (70\u2013150\u2009mg/m2) with a 1-week interval was attempted in 20 patients with pediatric advanced or chemotherapy-resistant solid tumors (seven rhabdomyosarcoma, four hepatoblastoma, three neuroblastoma and four other malignancy). Combinations of TEPA plus melphalan/busulfan (Bu) (8\u201310\u2009mg/kg) and TEPA plus Bu were given to four and two patients with brain tumors, respectively. In an additional two patients, three cycles of drug administration were performed. According to the results of the dose-escalating study, the maximum tolerable doses of TEPA and melphalan for children aged 2 years old or older were 1000\u2009mg/m2 and 280\u2009mg/m2, respectively. Mucositis was dose-limiting. Renal toxicity was also dose-limiting in young children (<2 years old). there were two treatment-related deaths (7%) (fungal pneumonia and renal tubular acidosis). among 13 patients who received high-dose chemotherapy during cr, 10 are alive with no evidence of disease (15\u201359\u2009months, median: 35 months) and in 13 evaluable patients without cr, six are alive without regrowth of the disease (14\u201359 months, median: 39 months). thus, these novel conditioning regimens allowed us to increase the dose intensity to nearly the maximum for each drug and seemed to reduce adverse effects compared to previously reported regimens with these drugs. with regard to the effect on outcome, the results of this study seem to be encouraging, but a further study on a larger number of patients is required.",
"genre": "article",
"id": "sg:pub.10.1038/sj.bmt.1701283",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1096890",
"issn": [
"0268-3369",
"1476-5365"
],
"name": "Bone Marrow Transplantation",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "22"
}
],
"keywords": [
"combination of thiotepa",
"solid tumors",
"chemotherapy-resistant solid tumors",
"major dose-limiting factor",
"high-dose thiotepa",
"life-threatening mucositis",
"double-conditioning regimen",
"dose-escalating study",
"treatment-related deaths",
"novel conditioning regimens",
"stem cell rescue",
"high-dose chemotherapy",
"evidence of disease",
"dose-limiting factor",
"cycles of administration",
"maximum tolerable doses",
"pediatric solid tumors",
"anti-cancer effects",
"evaluable patients",
"conditioning regimens",
"dose intensity",
"renal toxicity",
"tolerable doses",
"brain tumors",
"thiotepa",
"cell rescue",
"patients",
"Drug Administration",
"melphalan",
"maximum dose",
"regimens",
"single grafting",
"adverse effects",
"tumors",
"mucositis",
"drugs",
"busulfan",
"young children",
"Further studies",
"disease",
"administration",
"children",
"regimen",
"chemotherapy",
"neurotoxicity",
"dose",
"doses",
"study",
"death",
"outcomes",
"treatment",
"effect",
"toxicity",
"grafting",
"m2",
"years",
"interval",
"combination",
"evidence",
"rescue",
"factors",
"regrowth",
"large number",
"results",
"regard",
"cycle",
"number",
"Bu",
"intensity",
"Cr",
"maximum",
"limiting"
],
"name": "Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors",
"pagination": "7-12",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1012091956"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1038/sj.bmt.1701283"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"9678789"
]
}
],
"sameAs": [
"https://doi.org/10.1038/sj.bmt.1701283",
"https://app.dimensions.ai/details/publication/pub.1012091956"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T16:53",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_297.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1038/sj.bmt.1701283"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1701283'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1701283'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1701283'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1701283'
This table displays all metadata directly associated to this object as RDF triples.
265 TRIPLES
20 PREDICATES
112 URIs
104 LITERALS
22 BLANK NODES